Prasat Neurological Institute
Bangkok, 10400, Thailand
NCT Number: NCT01187277
The incidence of stroke in the industrial world is still high. Most of the patients are suffering from paresis of the affected side, speech and cognition problems. Modern concepts of motor learning after stroke favouring a task-specific repetitive high-intensity therapy approach to promote motor outcome. In the last couple of years robot-assisted therapy became an important part of modern rehabilitation after stroke. But so far there is no clear evidence that robot assisted therapy in combination with conventional therapy is more effective than conventional therapy alone to promote motor functions after stroke.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 3
Bangkok, 10400, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
conventional therapy means: 50 min individual physiotherapy and 60 min individual occupational therapy per work day (5x per week)for four consecutive weeks
individual physiotherapy +individual occupational therapy+ robotic gait assisted therapy
Other names: Gait trainer GT1
Time frame: 4 weeks
Description of ambulation level of the individual patient, whether and if, how much support is needed.
Time frame: 4 weeks
Assesses independence in activity of daily living
Time frame: 4 weeks
Assesses balance abilities.
Time frame: 4 weeks
Sum score to assess muscle tone for the major joints of the upper and lower extremities.
Prasat Neurological Institute
Other Gov
A Randomized Controlled Trial on Hemiplegic Gait Rehabilitation: Robotic Locomotor Training Versus Conventional Training in Subacute Stroke.
Acronym: BB200810
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01935544
Brain Diseases, Cardiovascular Diseases
Clermont-Ferrand, France
View Trial DetailsNCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial Details